January 26, 2023
As the first award to be granted under its new innovation program, the Coalition for Epidemic Preparedness Innovations (CEPI) will provide US$2 million to advance Tiba Biotech’s novel RNA nanoparticle delivery platform. See more -->
Karl Ruping
Computational Science, Intellectual Property Rights and Innovation
1 Broadway, 14th Fl., Cambridge, MA 02142
Latest News
- CEPI partners with Cambridge biotech to evaluate next-generation RNA vaccines
- Supreme Court to rule on epic copyright battle between Google and Oracle
- Tiba in international academic collaboration to develop a multi-antigen SARS-CoV-2 vaccine platform
- University of Pittsburgh Secures $1m NIH Grant for Collaboration with Tiba Biotech Developing RNA-based COVID-19 Vaccine
Copyright © 2024 The President and Fellows of Harvard College | Accessibility | Digital Accessibility | Report Copyright Infringement